We are live on ! Find out more
CPH

C Partners Holding Portfolio holdings

AUM $317M
1-Year Est. Return 4.76%
This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
-4.76%
3 Year Est. Return
+31.57%
5 Year Est. Return
+26.92%
10 Year Est. Return
+222.73%
AUM
$313M
AUM Growth
+$4.43M
Cap. Flow
+$3.21M
Cap. Flow %
1.03%
Top 10 Hldgs %
70.79%
Holding
53
New
4
Increased
6
Reduced
4
Closed
7

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$28.9M
2
AKRX
Akorn Inc
AKRX
+$1.5M
3
CERS icon
Cerus
CERS
+$1.2M
4
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$888K
5
BSX icon
Boston Scientific
BSX
+$790K

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$6.96M
2
ADMS
Adamas Pharmaceuticals
ADMS
+$6M
3
YUM icon
Yum! Brands
YUM
+$4.22M
4
QCOM icon
Qualcomm
QCOM
+$4.05M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.97M

Sector Composition

Rank Sector Weight
1 Healthcare 15.27%
2 Materials 12.1%
3 Consumer Discretionary 5%
4 Consumer Staples 2.88%
5 Industrials 2.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$618B
$3.03M 0.97%
30,089
-39,062
-56% -$3.97M
ABT icon
27
Abbott
ABT
$183B
$2.42M 0.77%
52,137
– –
ABBV icon
28
AbbVie
ABBV
$443B
$1.93M 0.62%
33,000
+7,000
+27% +$423K
CAH icon
29
Cardinal Health
CAH
$53.9B
$1.9M 0.61%
21,000
– –
HPTX
30
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.88M 0.6%
41,000
-18,000
-31% -$538K
BSX icon
31
Boston Scientific
BSX
$69.5B
$1.86M 0.6%
105,000
+50,000
+91% +$790K
PFE icon
32
Pfizer
PFE
$143B
$1.74M 0.56%
52,700
– –
RVTY icon
33
Revvity
RVTY
$12.6B
$1.69M 0.54%
33,000
– –
IQV icon
34
IQVIA
IQV
$38.7B
$1.67M 0.53%
25,000
– –
TEVA icon
35
Teva Pharmaceuticals
TEVA
$40.8B
$1.62M 0.52%
26,000
– –
AKRX
36
DELISTED
Akorn Inc
AKRX
$1.57M 0.5%
+33,000
New +$1.5M
PRGO icon
37
Perrigo
PRGO
$1.4B
$1.53M 0.49%
9,262
+3,100
+50% +$494K
BIIB icon
38
Biogen
BIIB
$30B
$1.52M 0.49%
3,600
-1,500
-29% -$591K
BDSI
39
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.26M 0.4%
120,000
+65,000
+118% +$888K
CERS icon
40
Cerus
CERS
$433M
$980K 0.31%
+235,000
New +$1.2M
TMO icon
41
Thermo Fisher Scientific
TMO
$213B
$846K 0.27%
6,300
– –
SYK icon
42
Stryker
SYK
$125B
$738K 0.24%
8,000
– –
SYNH
43
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$674K 0.22%
+20,600
New +$569K
DVAX
44
DELISTED
Dynavax Technologies
DVAX
$464K 0.15%
20,697
– –
RDUS
45
DELISTED
Radius Health, Inc.
RDUS
$395K 0.13%
+9,600
New +$431K
SCPX
46
DELISTED
Scorpius Holdings, Inc.
SCPX
– –
0
– –
MDT icon
47
Medtronic
MDT
$109B
– –
-96,346
Closed -$6.96M
QCOM icon
48
Qualcomm
QCOM
$155B
– –
-54,502
Closed -$4.05M
VTRS icon
49
Viatris
VTRS
$20.4B
– –
-58,000
Closed -$3.27M
YUM icon
50
Yum! Brands
YUM
$41.8B
– –
-80,582
Closed -$4.22M
1
2
3

Similar funds

KI
Keewaydin Investments Southampton, New York $317M AUM
CPW
Crestmont Private Wealth Houston, Texas $317M AUM 15.31% 1-Year Est. Return
GWP
Gen-Wealth Partners Zeeland, Michigan $317M AUM 17.24% 1-Year Est. Return
TM
TigerOak Management Albuquerque, New Mexico $317M AUM 25.39% 1-Year Est. Return
WIS
Wright Investors Service Shelton, Connecticut $318M AUM 33.9% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
FNWM
Financial Network Wealth Management Draper, Utah $316M AUM
GBFG
Gerald Baker Financial Group Arlington, Texas $316M AUM

C Partners Holding's Q1 2015 Portfolio in Review

As of Q1 2015, C Partners Holding held 53 positions worth $313M, up 1.4% from $309M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

C Partners Holding's Q1 2015 filing shows 4 new, 6 increased, 4 reduced and 7 closed positions. Its largest new stake was Akorn Inc: 33,000 shares worth $1.57M. The largest sale was Medtronic, an estimated $6.96M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Materials and Consumer Discretionary.

  • C Partners Holding's largest Q1 2015 buy was Akorn Inc: 33,000 shares worth $1.57M.
  • C Partners Holding added most to SPDR Gold Trust in Q1 2015, an estimated $28.9M increase.
  • C Partners Holding's biggest Q1 2015 reduction was Adamas Pharmaceuticals, cutting an estimated $6M.
  • C Partners Holding fully exited Medtronic in Q1 2015, selling an estimated $6.96M.
  • C Partners Holding's ten largest holdings make up 71% of its $313M portfolio in Q1 2015.
  • C Partners Holding opened 4 new positions and closed 7 in Q1 2015.
  • C Partners Holding's portfolio value rose 1.4% quarter-over-quarter to $313M.

Based on C Partners Holding's 13F filing for Q1 2015, filed 21 Apr 2015.